![DRAP Draft Guidance on Clinical Research: Responsibilities](https://www.regdesk.co/wp-content/uploads/2024/02/DRA-on-clinical-research-responsibilities.jpg)
DRAP Draft Guidance on Clinical Research: Responsibilities
The new article describes in detail the key responsibilities of the parties involved in clinical research.
The new article describes in detail the key responsibilities of the parties involved in clinical research.
The article provides a general overview of Pakistan’s regulatory requirements for clinical research.
The new article covers the aspects related to the application of the reliance approach to specific categories of healthcare products and also provides an overview of the reliance procedures. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP), a...
The new article highlights the aspects related to the application of the reliance approach in the context of marketing authorization for medical devices. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP), a country’s regulatory agency in the sphere of...
The new article highlights the aspects related to approvals for clinical trials, as well as pharmacovigilance practices. Table of Contents The Drug Regulatory Authority of Pakistan (DRAP), a country’s regulatory agency in the sphere of healthcare products, has...